These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 26298293)
1. A role for retromer in hepatitis C virus replication. Yin P; Hong Z; Yang X; Chung RT; Zhang L Cell Mol Life Sci; 2016 Feb; 73(4):869-81. PubMed ID: 26298293 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus NS5A hijacks ARFGAP1 to maintain a phosphatidylinositol 4-phosphate-enriched microenvironment. Li H; Yang X; Yang G; Hong Z; Zhou L; Yin P; Xiao Y; Chen L; Chung RT; Zhang L J Virol; 2014 Jun; 88(11):5956-66. PubMed ID: 24623438 [TBL] [Abstract][Full Text] [Related]
3. ARF1 and GBF1 generate a PI4P-enriched environment supportive of hepatitis C virus replication. Zhang L; Hong Z; Lin W; Shao RX; Goto K; Hsu VW; Chung RT PLoS One; 2012; 7(2):e32135. PubMed ID: 22359663 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus stimulates the phosphatidylinositol 4-kinase III alpha-dependent phosphatidylinositol 4-phosphate production that is essential for its replication. Berger KL; Kelly SM; Jordan TX; Tartell MA; Randall G J Virol; 2011 Sep; 85(17):8870-83. PubMed ID: 21697487 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis C Virus Subverts Human Choline Kinase-α To Bridge Phosphatidylinositol-4-Kinase IIIα (PI4KIIIα) and NS5A and Upregulates PI4KIIIα Activation, Thereby Promoting the Translocation of the Ternary Complex to the Endoplasmic Reticulum for Viral Replication. Wong MT; Chen SS J Virol; 2017 Aug; 91(16):. PubMed ID: 28566381 [TBL] [Abstract][Full Text] [Related]
6. Daclatasvir inhibits hepatitis C virus NS5A motility and hyper-accumulation of phosphoinositides. Chukkapalli V; Berger KL; Kelly SM; Thomas M; Deiters A; Randall G Virology; 2015 Feb; 476():168-179. PubMed ID: 25546252 [TBL] [Abstract][Full Text] [Related]
7. Lipid droplet-binding protein TIP47 regulates hepatitis C Virus RNA replication through interaction with the viral NS5A protein. Vogt DA; Camus G; Herker E; Webster BR; Tsou CL; Greene WC; Yen TS; Ott M PLoS Pathog; 2013; 9(4):e1003302. PubMed ID: 23593007 [TBL] [Abstract][Full Text] [Related]
8. Viperin inhibits hepatitis C virus replication by interfering with binding of NS5A to host protein hVAP-33. Wang S; Wu X; Pan T; Song W; Wang Y; Zhang F; Yuan Z J Gen Virol; 2012 Jan; 93(Pt 1):83-92. PubMed ID: 21957124 [TBL] [Abstract][Full Text] [Related]
9. The lipid kinase phosphatidylinositol-4 kinase III alpha regulates the phosphorylation status of hepatitis C virus NS5A. Reiss S; Harak C; Romero-Brey I; Radujkovic D; Klein R; Ruggieri A; Rebhan I; Bartenschlager R; Lohmann V PLoS Pathog; 2013 May; 9(5):e1003359. PubMed ID: 23675303 [TBL] [Abstract][Full Text] [Related]
10. Modulation of hepatitis C virus genome replication by glycosphingolipids and four-phosphate adaptor protein 2. Khan I; Katikaneni DS; Han Q; Sanchez-Felipe L; Hanada K; Ambrose RL; Mackenzie JM; Konan KV J Virol; 2014 Nov; 88(21):12276-95. PubMed ID: 25122779 [TBL] [Abstract][Full Text] [Related]
11. Nonstructural NS5A Protein Regulates LIM and SH3 Domain Protein 1 to Promote Hepatitis C Virus Propagation. Choi JW; Kim JW; Nguyen LP; Nguyen HC; Park EM; Choi DH; Han KM; Kang SM; Tark D; Lim YS; Hwang SB Mol Cells; 2020 May; 43(5):469-478. PubMed ID: 32344996 [TBL] [Abstract][Full Text] [Related]
12. Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment. Reiss S; Rebhan I; Backes P; Romero-Brey I; Erfle H; Matula P; Kaderali L; Poenisch M; Blankenburg H; Hiet MS; Longerich T; Diehl S; Ramirez F; Balla T; Rohr K; Kaul A; Bühler S; Pepperkok R; Lengauer T; Albrecht M; Eils R; Schirmacher P; Lohmann V; Bartenschlager R Cell Host Microbe; 2011 Jan; 9(1):32-45. PubMed ID: 21238945 [TBL] [Abstract][Full Text] [Related]
13. Metabolism of phosphatidylinositol 4-kinase IIIα-dependent PI4P Is subverted by HCV and is targeted by a 4-anilino quinazoline with antiviral activity. Bianco A; Reghellin V; Donnici L; Fenu S; Alvarez R; Baruffa C; Peri F; Pagani M; Abrignani S; Neddermann P; De Francesco R PLoS Pathog; 2012; 8(3):e1002576. PubMed ID: 22412376 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus NS5A protein interacts with phosphatidylinositol 4-kinase type IIIalpha and regulates viral propagation. Lim YS; Hwang SB J Biol Chem; 2011 Apr; 286(13):11290-8. PubMed ID: 21297162 [TBL] [Abstract][Full Text] [Related]
15. ISGylation of Hepatitis C Virus NS5A Protein Promotes Viral RNA Replication via Recruitment of Cyclophilin A. Abe T; Minami N; Bawono RG; Matsui C; Deng L; Fukuhara T; Matsuura Y; Shoji I J Virol; 2020 Sep; 94(20):. PubMed ID: 32727878 [TBL] [Abstract][Full Text] [Related]
16. Nir2 Is an Effector of VAPs Necessary for Efficient Hepatitis C Virus Replication and Phosphatidylinositol 4-Phosphate Enrichment at the Viral Replication Organelle. Wang H; Tai AW J Virol; 2019 Nov; 93(22):. PubMed ID: 31484747 [TBL] [Abstract][Full Text] [Related]
17. Interaction between Nonstructural Proteins NS4B and NS5A Is Essential for Proper NS5A Localization and Hepatitis C Virus RNA Replication. Biswas A; Treadaway J; Tellinghuisen TL J Virol; 2016 Aug; 90(16):7205-7218. PubMed ID: 27252526 [TBL] [Abstract][Full Text] [Related]
18. Cell culture-adaptive mutations in hepatitis C virus promote viral production by enhancing viral replication and release. Wang Q; Li Y; Liu SA; Xie W; Cheng J World J Gastroenterol; 2018 Mar; 24(12):1299-1311. PubMed ID: 29599605 [TBL] [Abstract][Full Text] [Related]
19. Human VAP-C negatively regulates hepatitis C virus propagation. Kukihara H; Moriishi K; Taguwa S; Tani H; Abe T; Mori Y; Suzuki T; Fukuhara T; Taketomi A; Maehara Y; Matsuura Y J Virol; 2009 Aug; 83(16):7959-69. PubMed ID: 19515777 [TBL] [Abstract][Full Text] [Related]
20. Y-Box Binding Protein 1 Stabilizes Hepatitis C Virus NS5A via Phosphorylation-Mediated Interaction with NS5A To Regulate Viral Propagation. Wang WT; Tsai TY; Chao CH; Lai BY; Wu Lee YH J Virol; 2015 Nov; 89(22):11584-602. PubMed ID: 26355086 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]